ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 37504367

Ampullary Cancer: Histological Subtypes, Markers, and Clinical Behaviour-State of the Art and Perspectives.

Nappo G and 7 others. Curr Oncol, 2023. Cited by 23 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Ampullary Cancer: Histological Subtypes, Markers, and Clinical Behaviour-State of the Art and Perspectives. Papers, record 37504367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37504367

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ampullary Cancer: Histological Subtypes, Markers, and Clinical Behaviour-State of the Art and Perspectives.
PubMed
Journal
Curr Oncol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
2.56
iCite
Revised in PubMed
2024-01-02
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nappo GGennarohttps://orcid.org/0000-0002-6048-898X
2Funel NNiccola
3Laurenti VVirginiahttps://orcid.org/0000-0001-6592-8844
4Stenner EElisabetta
5Carrara SSilvia
6Bozzarelli SSilvia
7Spaggiari PPaola
8Zerbi AAlessandrohttps://orcid.org/0000-0002-9176-0448

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Ampulla of VaterMajor topic
Common Bile Duct NeoplasmsMajor topic
Pancreatic NeoplasmsMajor topic
AdenocarcinomaMajor topic
Humans
Biomarkers, Tumor
Lead

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References62

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18,516,849The multistep nature of cancer.Trends Genet1993https://conductscience.org/library/papers/8516849PubMed
215,725,805Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.Am J Surg Pathol2005https://conductscience.org/library/papers/15725805PubMed
335,714,836Microsatellite instability in pancreatic and ampullary carcinomas: histology, molecular pathology, and clinical implications.Hum Pathol2023https://conductscience.org/library/papers/35714836PubMed
430,713,128Clinical relevance of pancreatobiliary and intestinal subtypes of ampullary and duodenal adenocarcinoma: Pattern of recurrence, chemotherapy, and survival after pancreatoduodenectomy.Pancreatology2019https://conductscience.org/library/papers/30713128PubMed
515,774,774Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.J Clin Oncol2005https://conductscience.org/library/papers/15774774PubMed
632,773,194Approaches to Biopsy and Resection Specimens from the Ampulla.Surg Pathol Clin2020https://conductscience.org/library/papers/32773194PubMed
729,506,768Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience.Eur J Surg Oncol2018https://conductscience.org/library/papers/29506768PubMed
815,549,428Pathogenesis of carcinoma of the papilla of Vater.J Hepatobiliary Pancreat Surg2004https://conductscience.org/library/papers/15549428PubMed
923,439,753Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater.J Clin Oncol2013https://conductscience.org/library/papers/23439753PubMed
1019,164,203Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater.J Clin Oncol2009https://conductscience.org/library/papers/19164203PubMed

1 to 10 of 62

See all 62 references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
42,948,310Prognostic significance of CK7, CK20, and CDX2 expression in small intestinal adenocarcinoma.ESMO Gastrointest Oncol2026https://conductscience.org/library/papers/42948310PubMed
42,741,001Case Report: Successful staged multidisciplinary management of concurrent duodenal papilla adenocarcinoma and cholelithiasis: a rare case in primary hospital.Front Surg2026https://conductscience.org/library/papers/42741001PubMed
42,703,401Histopathological subtypes independently predict survival in ampullary carcinoma: a contemporary SEER nomogram study.J Gastrointest Oncol2026https://conductscience.org/library/papers/42703401PubMed
42,406,030Immunohistochemical profiling of ampullary carcinoma: Molecular subtypes, prognostic markers, and the role of Claudin-18.Virchows Arch2026https://conductscience.org/library/papers/42406030PubMed
42,338,848Isolated Psoas Muscle Metastasis From Ampullary Carcinoma: A Report of a Rare Case.Cureus2026https://conductscience.org/library/papers/42338848PubMed
42,309,776Extrahepatic biliary obstruction due to ampullary carcinoma in a dog.J Vet Med Sci2026https://conductscience.org/library/papers/42309776PubMed
42,231,969Deciphering the single-cell molecular landscape of ampullary cancer: A rare gastrointestinal malignancy.iScience2026https://conductscience.org/library/papers/42231969PubMed
42,120,420Interpreting MALDI imaging data for rare types of ampullary cancer using machine learning.NPJ Syst Biol Appl2026https://conductscience.org/library/papers/42120420PubMed
41,684,016Rare, Yet Targetable: New Perspectives on Ampullary Carcinomas.Int J Mol Sci2026https://conductscience.org/library/papers/41684016PubMed
41,392,200Advanced ampullary cancer: post-hoc analysis of the ABC-01, ABC-02, and ABC-03 clinical trials.Oncologist2026https://conductscience.org/library/papers/41392200PubMed

1 to 10 of 21

See all 21 cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CDX21,045PubTator's text mininghttps://conductscience.org/library/genes/1045NCBI Gene
KRT2054,474PubTator's text mininghttps://conductscience.org/library/genes/54474NCBI Gene
KRT73,855PubTator's text mininghttps://conductscience.org/library/genes/3855NCBI Gene
MUC14,582PubTator's text mininghttps://conductscience.org/library/genes/4582NCBI Gene
MUC24,583PubTator's text mininghttps://conductscience.org/library/genes/4583NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37504367

GET https://conductscience.org/api/papers/v1/37504367/references?page=2

API referenceFor AI assistants